Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Tumor Vaccines Using Gpi-Linked Molecules
Segal, Andrew H.
Genitrix, LLC, Cambridge, MA, United States
Search 10 grants from Andrew Segal
Search grants from Genitrix, LLC
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Long-lived B cell Immunity in the Respiratory Tract
Cell Cycle/Apoptosis Gene Variants and Breast Cancer Risk
Metabolic Signals Regulating GLUT4 Expression in Vivo
Biosocial Histories of Mentally Retarded Young Adults
Selection of Lines for Ethanol-Induced Activity
Recently added grants:
Adenosinergic Signaling in the Immunoinflammatory Response After Cardiac Arrest
Telemedicine to Reduce Disparities in the Identification and Treatment of Neonatal Encephalopathy
Infectious Diseases and Inflammatory Disorders Training Program
Optimization of Lead BKIs for Cryptosporidiosis Therapy
Skeleton and Joint Degeneration with Aging
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA074665-01A1
Application #
2422939
Study Section
Special Emphasis Panel (ZRG2-SSS-4 (02))
Program Officer
Reynolds, Craig W
Project Start
1997-09-30
Project End
1999-06-30
Budget Start
1997-09-30
Budget End
1999-06-30
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Genitrix, LLC
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Related projects
NIH 1999
R43 CA
Development of Tumor Vaccines Using Gpi Linked Molecules
Segal, Andrew H. / Genitrix, LLC
NIH 1997
R43 CA
Development of Tumor Vaccines Using Gpi-Linked Molecules
Segal, Andrew H. / Genitrix, LLC
Comments
Be the first to comment on Andrew Segal's grant